Skip to content
E160 - 4/30 is the new 4/20! What we know about Schedule 3 episode artwork

EPISODE · May 2, 2024 · 23 MIN

E160 - 4/30 is the new 4/20! What we know about Schedule 3

from High Rise: Cannabis MSOs, Products & Market Analysis · host Headset, Inc.

In this conversation, Cy and Emily discuss the recent announcement by the DEA that they will recommend rescheduling cannabis to Schedule III. They explore the potential implications of this decision, including its impact on the capital markets, banking reform, and the ongoing Commerce Clause case. They also touch on the significance of this shift in the federal government's view of cannabis and the challenges that lie ahead in the implementation process. Overall, they express cautious optimism about the future of cannabis legalization in the United States. Takeaways The DEA's recommendation to reschedule cannabis to Schedule III represents a significant shift in the federal government's view of cannabis and acknowledges its potential positive benefits. While rescheduling alone does not immediately change the criminality around cannabis or allow for uplisting and banking reform, it sets a strong foundation for future progress. The rescheduling decision may pave the way for discussions on capital markets and banking reform, as well as potential memos from the DOJ and the impact of the Commerce Clause case. The implementation process and potential challenges, including legal battles and administrative procedures, will play a crucial role in determining the actual impact of rescheduling. Despite the uncertainties and challenges, there is a sense of cautious optimism about the future of cannabis legalization in the United States. Chapters 00:00 Introduction and Overview 03:02 DEA Recommends Rescheduling Cannabis to Schedule III 09:26 The Trauma and Optimism of Cannabis Legalization 13:49 The Implications of Rescheduling 16:13 The Commerce Clause Case and Fair Application of the CSA Keywords DEA, rescheduling, cannabis, Schedule III, capital markets, banking reform, Commerce Clause case, implementation process, federal government, legalization Headset

Episode metadata supplied by the publisher feed · Published May 2, 2024

Embed this episode

In this conversation, Cy and Emily discuss the recent announcement by the DEA that they will recommend rescheduling cannabis to Schedule III. They explore the potential implications of this decision, including its impact on the capital markets, banking reform, and the ongoing Commerce Clause case. They also touch on the significance of this shift in the federal government's view of cannabis and the challenges that lie ahead in the implementation process. Overall, they express cautious optimis...

Distinct summary based on available episode metadata or transcript content.

Ready to play

E160 - 4/30 is the new 4/20! What we know about Schedule 3

0:00 23:03

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

The Investor's Podcast (We Study Billionaires) - The Investor’s Podcast Network The Investor's Podcast Network Hosted by Stig Brodersen, William Green, Shawn O'Malley, Daniel Mahncke, and Kyle Grieve, The Investor’s Podcast has proudly reached nearly 200 million downloads, as the world's largest stock-investing focused podcast. On the show, we study a range of businesses and their investment prospects, from Spotify to Amazon, serial acquirers like Constellation Software, deep value plays, and more, using lessons from some of the world's most famous investors, like Warren Buffett, Charlie Munger, and Howard Marks. Leverage the lessons we learned from studying, and talking to, the wo Capital Ideas podcast Capital Group Want to learn how professional investors do it? The Capital Ideas podcast brings you the latest investment thinking from Capital Group, one of the world's largest investment management organizations. Each week we'll get inside the minds of portfolio managers, analysts and economists to break down market trends, macroeconomic forces, investing approaches and lessons learned from personal experience. Take 30 minutes and tap into the intellectual capital of Capital Group. Capital Client Group, Inc.All Capital Group trademarks mentioned are owned by The Capital Group Companies, Inc., an affiliated company or fund. All other company and product names mentioned are the property of their respective companies.For full disclosures go to capitalgroup.com/global-disclosures.

Frequently Asked Questions

How long is this episode of High Rise: Cannabis MSOs, Products & Market Analysis?

This episode is 23 minutes long.

When was this High Rise: Cannabis MSOs, Products & Market Analysis episode published?

This episode was published on May 2, 2024.

Can I download this High Rise: Cannabis MSOs, Products & Market Analysis episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!